The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Top Cited Papers
- 18 August 2010
- journal article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 11 (9), 642-651
- https://doi.org/10.1038/nrn2884
Abstract
After a pause of nearly 40 years in research into the effects of psychedelic drugs, recent advances in our understanding of the neurobiology of psychedelics, such as lysergic acid diethylamide (LSD), psilocybin and ketamine have led to renewed interest in the clinical potential of psychedelics in the treatment of various psychiatric disorders. Recent behavioural and neuroimaging data show that psychedelics modulate neural circuits that have been implicated in mood and affective disorders, and can reduce the clinical symptoms of these disorders. These findings raise the possibility that research into psychedelics might identify novel therapeutic mechanisms and approaches that are based on glutamate-driven neuroplasticity.Keywords
This publication has 128 references indexed in Scilit:
- CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signalingNature Neuroscience, 2010
- Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to KetamineNeuropsychopharmacology, 2010
- Ketamine and the next generation of antidepressants with a rapid onset of actionPharmacology & Therapeutics, 2009
- Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophreniaDrug Discovery Today, 2009
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant DepressionBiological Psychiatry, 2009
- Modeling “psychosis” in vitro by inducing disordered neuronal network activity in cortical brain slicesPsychopharmacology, 2009
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate AntagonistBiological Psychiatry, 2008
- Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to KetamineBiological Psychiatry, 2008
- Cognitive therapy versus medication for depression: treatment outcomes and neural mechanismsNature Reviews Neuroscience, 2008
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008